lvv-hemorphin-7 has been researched along with leucine in 1 studies
Studies (lvv-hemorphin-7) | Trials (lvv-hemorphin-7) | Recent Studies (post-2010) (lvv-hemorphin-7) | Studies (leucine) | Trials (leucine) | Recent Studies (post-2010) (leucine) |
---|---|---|---|---|---|
59 | 0 | 14 | 28,515 | 744 | 4,178 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Albiston, AL; Chai, SY; Lew, RA; McDowall, SG; Mustafa, T; Ye, S | 1 |
1 other study(ies) available for lvv-hemorphin-7 and leucine
Article | Year |
---|---|
Angiotensin AT4 ligands are potent, competitive inhibitors of insulin regulated aminopeptidase (IRAP).
Topics: Aminopeptidases; Angiotensin II; Angiotensin Receptor Antagonists; Binding, Competitive; Cell Line; Cystinyl Aminopeptidase; Enzyme Activation; Enzyme Inhibitors; Hemoglobins; Humans; Kidney; Leucine; Ligands; Oligopeptides; Peptide Fragments; Peptides; Receptors, Angiotensin; Recombinant Proteins; Substrate Specificity | 2003 |